2014, Number 05
<< Back Next >>
Ginecol Obstet Mex 2014; 82 (05)
Primary carcinoma of the peritoneum. Case report and literature review
Togo PJM, Gómez PJI, Togo OLR, Montoya RJJ
Language: Spanish
References: 15
Page: 344-349
PDF size: 310.27 Kb.
ABSTRACT
Peritoneal primary carcinoma is an unusual tumor originated on the
pelvic and abdominal peritoneal surface. It is believed that it is originates
from a secondary müllerian system giving place to a peritoneal primary
carcinoma very similar to the epithelial ovarian cancer in its clinical
presentation, histological aspect, spread patron and its treatment and
prognosis. It´s complex clinical presentation difficult the differentiation
from an epithelial tumors from the ovary. Both tumors present
ascitis, elevated CA 125 and signs of peritoneal carcinomatosis on the
tomographic images. In this report is exposed the case of a 39 years
old women with a pre-surgical diagnosis of primary carcinoma of the
ovarian, wich was discarded during surgery founding that the primary
tumor was on the peritoneal surface of the descending colon.
REFERENCES
Bloss JD, Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 1993;50:347-351.
Eltabbakh GH, Piver MS. Oncology. 12ª ed. Washington: Williston Park, 1998; 813-819.
Tsujimura T, Takeda M, Terada N, Uramoto H. Two cases peritoneal serous papillary adenocarcinoma. Acta Pathol Jpn 1991;41:642-646.
Von Riedenauer WB, Janjua SA, Kwon DS, Zhang Z, Velanovich V. Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report. J Med Case Rep 2007;1:150.
Zissin R, Hertz M, Shapiro-Feinberg M, Bernheim J, Altaras M, Fishman A. Primary serous papillary carcinoma of the peritoneum: CT findings. Clin Radiol 2001;9:740-745.
Chopra S, Laurie LR, Chintapalli KN, Valente PT, Dodd GD. Primary papillaryserous carcinoma of the peritoneum: CT pathologic correlation. J Comput Assist Tomogr 2000;24:395-399.
Zanaboni F, Vergadoro F, Presti M, Gallotti P, et al. Tumor antigen Ca 125 as a marker of ovarian epithelial carcinoma. Gynecol Oncol 1987;28:61-67.
Barutcu O, Erel HE, Saygili E, Yildirim T, Torun D. Abdominopelvic tuberculosis simulating disseminated ovarian carcinoma with elevated Ca-125 level:. Abdom Imaging 2002;4:465-470.
Kebapci M, Vardareli E, Adapinar B, Acikalin M. CT findings and serum Ca-125 levels in malignant peritoneal mesothelioma: report. Eur Radiol 2003;12:2620-2626.
Loggie BW. Malignant peritoneal mesothelioma. Curr Treat Options 2001;2:395-399.
Ordóñez, NG. Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Arch Pathol Lab Med 2005;129:1407-1414.
Ordonez, NG. The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between. Mod Pathol 2006;19:34-48.
Barnetson RJ, Burnett RA, Downie I, Harper CM, Roberts F. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous. Am J Clin Pathol 2006;125:67-76.
Anonymous. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast. Br J Cancer 2000;83:1301-1310.
Whittemore AS, Gong G, John EM, McGuire V, et al. Prevalence of BRCA1 mutations carriers among non-Hispanic Whites. Cancer Epidemiol Biomarkers 2004;13:2078- 2083.